|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | In vitro me- tabolism of modazolam, triazolam, nifedipine, and testoster- one by human liver microsomes and recombinant cytochrome es p450: roles of P4503A4 and P4503A5 显示文摘 | KIRAN C PATKI LISA L YON MOLTKE | 2003 | DMD2003，，31： | 1 |
| 2 | A combined approach to drug metabolism and toxicity assessment 显示文摘 | EKINS S ANDREYEV S RYAVBOV A | 2006 | DMD2006，34，2： | 1 |
| 3 | Evaluation of cr- yopreserved human hepatocytes as an alternative in vitro system to microsomes for the prediction of metabolic clearance 显示文摘 | HAYLEY S BROWN GRIFFIN M | 2007 | DMD2007，35，2： | 1 |
| 4 | Multiple substrate binding by cytochrome CYP 3A4: estimation of the number of bound substrate molecules 显示文摘 | KAPELYUKH Y PAINE M I MARECHAL J D | 2008 | DMD2008，36，10： | 1 |
| 5 | Functional assessment of ABCG2(BCRP) gene polymorphisms to protein expression in human placenta 显示文摘 | Daisuke K | 2005 | DMD2005，33，1： | 1 |
| 6 | In vitro metabolism of modazolam, triazolam, nifedipine, and testosterone by human liver microsomes and recombinant cytochromees CYP: roles of CYP3A4 and CYP3A5 显示文摘 | PATKI K C VON MOLTKE L L GREENBLATI' D J | 2003 | DMD2003，31，4： | 1 |
| 7 | Multiple substrate binding by cytochrome CYP 3A4:estimation of the number of bound substrate molecules显示文摘 | Yury K Mark J I P Jean-Didier M | 2008 | DMD2008，，36： | 1 |
| 8 | Esomeprazole 40 mg provides improved intragastric acid control as compared with lansoprazole 30 mg and rabeprazole on human cytochrome P450 activities显示文摘 | Wilder-Smith CH Rohhss K Nilsson-Pieschl C | 2004 | DMD2004，32，5： | 1 |
| 9 | In vitro metabolism of modazolam,triazolam,Nifedipine,and testosterone by human liver microsomes and recombinant cytochrome CPY:roles of CYP3A4 and CYP3A5显示文摘 | Kiran C P Lisa L Von M | 2003 | DMD2003，，31： | 1 |
| 10 | Evaluation of cryopreserved human hepatocytes as an alternative in vitro system to microsomes for the prediction of metabolic clearance显示文摘 | Hayley S Brown Michael G | 2007 | DMD2007，，35： | 1 |
| 11 | ACombinedApproachtoDrugMetabolismandToxicityAssessment显示文摘 | SEANEKINS SERGEYANDREYEV ANDYRABOVY etal | 2006 | DMD2006，34，3： | 1 |
| 12 | Morin (3, 5, 7,2, 4,-pentahydroxyflavone) exhibits potent inhibitory actions on uratetransport by the human urate anion transporter (hURATl) expressed inhuman embryonic kidney cells显示文摘 | YU Zhifeng FONG Wingping CHENG C | 2007 | DMD2007，35，6： | 1 |
| 13 | MultipleSubstrateBindingbyCytochromeCYP3A4:EstimationoftheNumberofBoundSubstrateMolecules显示文摘 | YURYKAPELYUKH MARKJIPAINE JEAN-DIDIER MARECHAL etal | 2008 | DMD2008，36，10： | 1 |
| 14 | Comparison of inhibitory effects of the proton pump-inhibitory drugs omeprazole,asomeprazole,lansoprazole,pantoprazole,and rabeprazole on human cytochrome P450 activities显示文摘 | Li XQ Andersso TB Ahlstrom M | 2004 | DMD2004，32，5： | 1 |
| 15 | Phase I and Phase 2 Drug Metabolism and Bile Acid Production of HepaRG Ceils in a Bioartificial Liver in Absence of Dimethyl Sulfoxide 显示文摘 | Hoekstra R Nibourg GA Van Der Hoeven TV | 2013 | DMD2013，41，3： | 1 |
| 16 | The Tissue-Specific Toxicityof Methimazole in the Mouse Olfactory Mucosa Is Partly Medi-ated through Target-Tissue Metabolic Activation by CYP2A5显示文摘 | Xie F Zhou X Genter M B | 2011 | DMD2011，39，6： | 1 |
| 17 | Glutathione S-transferase activity influences busulfan phamaeokinetics in patients wit Beta thalassemia major undergoing bone marrow transplantation 显示文摘 | POONKUZHZLI B CHANDY M SRIVASTAVA A | 2001 | DMD2001，29，3： | 1 |
| 18 | Ethanol Induction ofCYP2A5:Permissive Role for CYP2E1显示文摘 | Lu Y K Zhuge J Wu D F | 2011 | DMD2011，39，2： | 1 |
| 19 | Regional expression and activity ofbreast cancer resistance protein(Bcrp/Abcg2)in mouse intestine:O-verlapping distribution with sulfotransferases显示文摘 | Junichi E Hiroyuki K Yuichi S | 2007 | DMD2007，35，： | 1 |
| 20 | Regulation ofCYP2A5 Gene by the Transcription Factor Nuclear Factor(Erythroid-Derived 2)-Like 2显示文摘 | Abu-Bakar A LamsaV Arpiainen S | 2007 | DMD2007，35，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员